Anne Tybjærg-Hansen

Medicine & Life Sciences

1. Myocardial Ischemia 100%
2. Population 82%
3. Random Allocation 59%
4. Genotype 58%
5. Myocardial Infarction 50%
6. Heterozygote 49%
7. LDL Cholesterol 48%
8. Meta-Analysis 48%
9. Lipoprotein(a) 46%
10. Cardiovascular Diseases 43%
11. Heart 41%
12. Chronic Obstructive Pulmonary Disease 40%
13. HDL Cholesterol 39%
14. Mutation 38%
15. Triglycerides 38%
16. Confidence Intervals 38%
17. Genetic Variation 35%
18. Cholesterol 34%
19. C-Reactive Protein 33%
20. Alleles 31%
21. Odds Ratio 31%
22. Vascular Diseases 31%
23. Genes 29%
24. Coronary Disease 28%
25. Body Mass Index 26%
26. Cerebrovascular Disorders 24%
27. Stroke 24%
28. Homozygote 23%
29. HDL Lipoproteins 23%
30. Gallstones 22%
31. Lipoproteins 22%
32. Single Nucleotide Polymorphism 22%
33. Apolipoproteins E 22%
34. Type 2 Diabetes Mellitus 21%
35. Apolipoproteins B 21%
36. Prospective Studies 21%
37. Genome-Wide Association Study 20%
38. Hyperlipoproteinemia Type II 19%
39. Lung 19%
40. Transferrin 19%
41. Mortality 18%
42. Lipids 18%
43. Cohort Studies 17%
44. Mendelian Randomization Analysis 17%
45. Venous Thromboembolism 16%
46. Adrenergic Receptors 16%
47. Blood Pressure 16%
48. ATP-Binding Cassette Transporters 16%
49. Arrhythmogenic Right Ventricular Dysplasia 16%
50. Case-Control Studies 15%